Skip to main content
SpringerLink
Log in

Stratégie thérapeutique initiale dans les cancers bronchiques non à petites cellules

  • Chapter
Oncologie thoracique

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 384 Accesses

Résumé

La stratégie thérapeutique des cancers doit reposer sur l’usage de référentiels et faire l’objet d’une discussion au cours d’une réunion de concertation pluridisciplinaire pour déboucher sur la présentation au patient de son programme personnalisé de soins. La décision thérapeutique prend en compte plusieurs paramètres, parmi lesquels l’extension de la maladie, le type histologique, l’état général du patient, son âge, ses comorbidités et le contexte socio-psychologique. Nous n’aborderons pas dans ce chapitre le traitement des patients dont l’état général est altéré et des sujets âgés qui fait l’objet d’autres chapitres.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Goldstraw P, Crowley J, Chansky K et al. (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706–714

    Article  PubMed  Google Scholar 

  2. Butts CA, Ding K, Seymour L et al. (2010) Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 28: 29–34

    Article  PubMed  CAS  Google Scholar 

  3. Strauss, G.M., Herndon JE, Maddaus MA et al. (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26: 5043–5051

    Article  PubMed  CAS  Google Scholar 

  4. Pignon JP, Tribodet H, Scagliotti GV et al. (2006) Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,854 patients. Proc Am Soc Clin Oncol 24(18S): 366s

    Google Scholar 

  5. NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, Burdett S et al. (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375: 1267–1277

    Article  PubMed  CAS  Google Scholar 

  6. Westeel V, Milleron BJ, Quoix EA et al. (2010) Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer. J Clin Oncol 28: 515s

    Article  Google Scholar 

  7. Pisters KM, Vallières E, Crowley JJ et al. (2010) Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 28: 1843–1849

    Article  PubMed  CAS  Google Scholar 

  8. Robinson, L.A., Ruckdeschel JC, Wagner H Jr et al. (2007) Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl): 243S–265S

    Article  PubMed  Google Scholar 

  9. PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352: 257–263

    Article  Google Scholar 

  10. Burdett S, Stewart L (2005) Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 47: 81–83

    Article  PubMed  Google Scholar 

  11. Douillard JY, Rosell R, De Lena M et al. (2008) Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 72: 695–701

    Article  PubMed  CAS  Google Scholar 

  12. Okawara G, Yee CU, Markman BR et al. (2004) Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 44: 1–11

    Article  PubMed  Google Scholar 

  13. Moretti L, Yu DS, Chen H et al. (2009) Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist 14: 1106–1115

    Article  PubMed  Google Scholar 

  14. Van Meerbeeck JP, Kramer G, Van Schil P et al. (2007) Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99: 442–450

    Article  PubMed  Google Scholar 

  15. Albain KS, Swann RS, Rusch VW et al. (2009) Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 374: 379–386

    Article  PubMed  CAS  Google Scholar 

  16. Auperin A, Le Péchoux C, Rolland E et al. (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28: 2181–2190

    Article  PubMed  CAS  Google Scholar 

  17. Vokes EE, Herndon JE, Kelley MJ et al. (2007) Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25: 1698–1704

    Article  PubMed  CAS  Google Scholar 

  18. Hanna, N., Neubauer M, Yiannoutsos C et al. (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26: 5755–5760

    Article  PubMed  CAS  Google Scholar 

  19. Segawa Y, Kiura K, Takigawa N et al. (2010) Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol 28: 3299–3306

    Article  PubMed  CAS  Google Scholar 

  20. NSCLC Meta-analyses Collaborative Group (2008) Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26: 4617–4625

    Article  Google Scholar 

  21. Ardizzoni A, Boni L, Tiseo M et al. (2007) Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99: 847–857

    Article  PubMed  CAS  Google Scholar 

  22. Hotta K, Matsuo K, Ueoka H et al. (2004) Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22: 3852–3859

    Article  PubMed  CAS  Google Scholar 

  23. Scagliotti GV, Parikh P, von Pawel J et al. (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543–3551

    Article  PubMed  CAS  Google Scholar 

  24. Ceppi P, Volante M, Saviozzi S et al. (2006) Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 107: 1589–1596

    Article  PubMed  CAS  Google Scholar 

  25. Schiller JH, Harrington D, Belani CP et al. (2000) A Randomized Phase III Trial of Four Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer. Proc Am Soc Clin Oncol 19: 1a

    Google Scholar 

  26. Azzoli CG, Baker S Jr, Temin S et al. (2009) American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27: 6251–6266

    Article  PubMed  CAS  Google Scholar 

  27. Ciuleanu T, Brodowicz T, Zielinski C et al. (2009) Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 374: 1432–1440

    Article  PubMed  CAS  Google Scholar 

  28. Cappuzzo F, Ciuleanu T, Stelmakh L et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol 11: 521–529

    Google Scholar 

  29. Perol M et al. (2010) Maintenance with either gemcitabine or erlotinib versus observation with predifened second-line treatment after cispatin-gemcitabine induction chemotherapy in advanced NSCLC: the IFCT-GFPC 0502 study. Proc ASCO, 28: 540s

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de pneumologie, Centre hospitalier universitaire Jean Minjoz, Boulevard Fleming, 25030, Besançon Cedex

    V. Westeel, P. Jacoulet & A. Marescaux

Authors
  1. V. Westeel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Jacoulet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Marescaux
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Westeel, V., Jacoulet, P., Marescaux, A. (2011). Stratégie thérapeutique initiale dans les cancers bronchiques non à petites cellules. In: Oncologie thoracique. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-99041-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-99041-0_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-99040-3

  • Online ISBN: 978-2-287-99041-0

Publish with us

Policies and ethics

Search

Navigation